A Review of Recent Evidence from Meal-Based Diet Interventions and Clinical Biomarkers for Improvement of Glucose Regulation

In recent decades, the prevalence of diabetes has rapidly increased worldwide. Medical nutrition therapy has been identified as a major therapeutic support for diabetic patients, while preventive strategies in prediabetic or high-risk individuals have mainly focused on supplementation with bioactive...

Full description

Saved in:
Bibliographic Details
Published inPreventive nutrition and food science Vol. 25; no. 1; pp. 9 - 24
Main Authors Jeong, Yeseung, Lee, Eunbi, Park, Yoon Jung, Kim, Yangha, Kwon, Oran, Kim, Yuri
Format Journal Article
LanguageEnglish
Published Korea (South) 한국식품영양과학회 31.03.2020
The Korean Society of Food Science and Nutrition
Subjects
Online AccessGet full text
ISSN2287-1098
2287-8602
2287-8602
DOI10.3746/pnf.2020.25.1.9

Cover

More Information
Summary:In recent decades, the prevalence of diabetes has rapidly increased worldwide. Medical nutrition therapy has been identified as a major therapeutic support for diabetic patients, while preventive strategies in prediabetic or high-risk individuals have mainly focused on supplementation with bioactive compounds. Recently, meal-based interventions have been investigated as novel and safe long-term strategies for improving glucose regulation. However, evaluation of meal-based interventions is difficult since it requires analysis of sensitive markers. Biomarkers can also be used to identify individuals at risk for diabetes, which is important for disease prevention. In this review, we summarize current evidence from meal-based intervention studies conducted with the aim of improving glucose homeostasis in individuals at risk of diabetes using clinical biomarkers currently used to assess diabetic risk. Very low-calorie diets have significantly improved glucose regulation in obese adults and in adults with type 2 diabetes mellitus. In particular, changing the ratios of macronutrients through calorie restriction reduces fasting glucose level and hemoglobin A1c levels in patients with diabetes mellitus. However, this effect is limited in both obese and healthy adults. To date, multiple glucose-related markers have been identified as clinical biomarkers of diabetes. Additional clinical biomarkers include cholesterol levels, hematological markers, and inflammatory markers. Taken together, the evidence presented in this review may help for selection of clinical biomarkers for meal-based preventive approaches for non- or pre-diabetic individuals to prevent onset of diabetes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
These authors contributed equally to this work.
Author information: Yeseung Jeong (Graduate Student), Eunbi Lee (Graduate Student), Yoon Jung Park (Professor), Yangha Kim (Professor), Oran Kwon (Professor), Yuri Kim (Professor)
ISSN:2287-1098
2287-8602
2287-8602
DOI:10.3746/pnf.2020.25.1.9